Lumipulse G ROMA— 510(k) K160090

Substantially Equivalent

Fujirebio Diagnostics,Inc.

FDA 510(k) clearance K160090 for Lumipulse G ROMA, Substantially Equivalent on 2016-05-16. Applicant: Fujirebio Diagnostics,Inc.. Device class: 2.

Clearance details

Applicant: Fujirebio Diagnostics,Inc.
Product code: Code ONX
Device class: Class 2
Regulation: 21 CFR 866.6050
Advisory panel: Obstetrics/Gynecology
Date received: 2016-01-15
Decision date: 2016-05-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code ONX

K153607 — ROMA Calculation Tool Using Elecsys Assays2016-06-15
K151502 — ARCHITECT ROMA2016-04-28
K150588 — OVA1 Next Generation2016-03-18
K103358 — ROMA (HE4 EIA + ARCHITECT CA 125 II)2011-09-01
DEN090004 — OVA1 TEST2009-09-11

More clearances from Fujirebio Diagnostics,Inc.

K250925 — ADVIA Centaur Cytokeratin Fragment 21-12025-12-16
K242706 — Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio2025-05-16
DEN200072 — Lumipulse G ß-Amyloid Ratio (1-42/1-40)2022-05-04
K192524 — Lumipulse G CA15-32020-09-04
K192380 — ST AIA-PACK BNP2020-08-24

Data sourced from openFDA. This site is unofficial and independent of the FDA.